Talks are underway between the Democratic Republic of the Congo and the WHO to expedite the start of a multi-armed Phase 3 clinical trial of Ebola vaccines.

The Trump administration on Wednesday unveiled a new framework for helping Americans facing the often-intertwined circumstances of addiction and homelessness. In a new toolkit, th ...

Shortly after her wedding four years ago, Jenilee Crowley felt ready to start having kids. Then the 38-year-old found a lump in her breast that upended all her future plans. Chemotherapy, radiation, ...

Our understanding and treatment of postpartum psychiatric illnesses remain profoundly inadequate,” experts write.

Waiting for treatment to start can be an excruciating period for cancer patients. There can be fears that the disease is spreading, or progressing to a point where therapies becom ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Eli Lilly filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of its experimental obesity drug retatrutide ...

Sarah covers how industries like food and tobacco affect Americans’ bodies and minds. Her interests include ultra-processed foods; smoke-free tobacco; and wellness trends like perimenopause products ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Definium Therapeutics said Wednesday that ...

Tara covers the business of health care. Her stories focus on hospitals, doctors, and how their business practices affect patients — especially when private equity gets involved. She also writes about ...

It's no mystery. History tells us that President Trump’s executive order calling for the MMR to be split into separate shots could do real harm.

Not long after guidelines shifted to considering statin therapy as early as age 30, new research from France suggests there may be no harm in stopping the cholesterol-lowering drugs at age 75 in ...